Koligo Therapeutics (ASX:KOL) Total Inventories: A$0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Koligo Therapeutics Total Inventories?

Koligo Therapeutics ASX:KOL Total Inventories is A$0.00 Mil as of . 20.

Koligo Therapeutics's total inventories for the quarter that ended in . 20 was A$0.00 Mil. Koligo Therapeutics's average total inventories from the quarter that ended in . 20 to the quarter that ended in . 20 was A$0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Koligo Therapeutics's Net-Net Working Capital per share for the quarter that ended in . 20 was A$N/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Koligo Therapeutics  (ASX:KOL) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Koligo Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in . 20 is

Net-Net Working Capital Per Share (Q: . 20 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(+0.75 * +0.5 * -N/A
--)/0
=N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Koligo Therapeutics's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory=Average Total Inventories (Q: . 20 )/Cost of Goods Sold (Q: . 20 )*Days in Period
=0/*365 / 2
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Koligo Therapeutics's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: . 20 ) / Average Total Inventories (Q: . 20 )
= / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Koligo Therapeutics's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: . 20 ) / Revenue (Q: . 20 )
=0 /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Koligo Therapeutics Total Inventories Related Terms

Koligo Therapeutics Total Inventories Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Total Inventories Chart

Koligo Therapeutics Annual Data
Trend
Total Inventories

Koligo Therapeutics Semi-Annual Data
Total Inventories

Koligo Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of A$0.00 Mil mean?
Koligo Therapeutics (ASX:KOL) has a Total Inventories of A$0.00 Mil as of . 20. The total amount of inventory as recorded on a company's balance sheet. View historical data for Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Total Inventories too high?
Koligo Therapeutics' current Total Inventories is A$0.00 Mil.
How does Koligo Therapeutics' Total Inventories compare to ?
Koligo Therapeutics' Total Inventories of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Koligo Therapeutics and its competitors. Koligo Therapeutics's current Total Inventories is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Total Inventories of A$0.00 Mil. The current Total Inventories is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Total Inventories is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies